Cannon Global Investment Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Cannon Global Investment Management’s Portfolio ITCI Stock Details ITCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-5,112	Closed	-$674K	–	121
2025 Q1	$674K	Buy	+5,112	New	+$637K	1.18%	19

Other funds holding ITCI

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

KIM

Kestra Investment Management Austin, Texas $5.8B AUM 14.71% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Cannon Global Investment Management's ITCI Position: Q2 2025 in Review

Cannon Global Investment Management sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 5,112 shares — an estimated $674K sold.

Cannon Global Investment Management first reported a position in ITCI in Q1 2025 and held it in 1 quarter. The position peaked at $674K in Q1 2025. 4 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

Cannon Global Investment Management reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
Cannon Global Investment Management sold 5,112 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $674K.
Cannon Global Investment Management first reported a position in Intra-Cellular Therapies Inc. in Q1 2025 and held it in 1 quarter.
Cannon Global Investment Management's Intra-Cellular Therapies Inc. position peaked at $674K in Q1 2025.
4 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on Cannon Global Investment Management's 13F filing for Q2 2025, filed 29 Jul 2025.